J R Hurst Thorax 2010 65: 85-90 Depart. Of Pulmonology R3 백승숙.

Slides:



Advertisements
Similar presentations
Definition of COPD COPD is a preventable and treatable disease with some significant extrapulmonary effects that may contribute to the severity in individual.
Advertisements

GOLD MANAGEMENT PLAN FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Caring for Patients with COPD: Guidelines for Diagnosis and Management M. Elizabeth Knauft, MD MS September 20, 2007.
BY DR.Khaled Helmy Chest Specialist Al Mahmora Chest Hospital Ministry of Health - Egypt COPD SCOPE ON.
Bronchoprovocation test Presented by: Ashraf Abbas ELMaraghy,MD. Lecturer of Chest Diseases, Ain Shams University.
Infection in COPD Pulmonology Subspeciality Rounds (12/11/2008)Dr.Krock Dr.Vysetti Dr.Vysetti.
Optimizing the Management of Chronic Obstructive Pulmonary Disease (COPD) Note to the Speaker: All bold underlined statements must be read aloud to the.
Academy Board Prep PCCM
Physiology Lab Spirometry
นส. นุชนาถ ตั้งเวนิช เจริญสุข รหัส A chronic inflammatory disorder of the airway Airway hyperresponsiveness Recurrent episodes of wheezing,
2008 Guidelines 2.4 DIAGNOSIS IN ADULTS (1) -based on the recognition of a characteristic pattern of symptoms and signs and the absence of an alternative.
Professor of Respiratory Medicine
Identifying COPD in primary care: targeting patients at the highest risk What is COPD? Chronic obstructive pulmonary disease or COPD is a long-term inflammatory.
Dr Patrick Mallia MD PhD NIHR Clinical Lecturer
Dr. Danny Galdermans Dept Respiratory Medicine ZNA Middelheim Antwerp
Bronchial provocation Tests or Bronchial challenge Test
Asthma What is Asthma ? V1.0 1997 Merck & ..
CHRONIC OBSTRUCTIVE PULMONARY DISEASE ZULEYHA OZEN.
Definition of COPD COPD is a preventable and treatable disease with some significant extrapulmonary effects that may contribute to the severity in individual.
22/06/2011.  Asthma – an introduction (Vanessa)  Diagnosis and management of chronic asthma in line with current BTS guidelines (Dr Lowery)  3 x Case.
HIGH DOSES OF VITAMIN D TO REDUCE EXACERBATION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A RANDOMIZED TRIAL An Lehouck, PhD; Chantal Mathieu, MD, PhD;
Practice Support Program in COPD: South Okanagan Project COPD CARE Algorithm South Okanagan, Interior Health Patricia Rattee RRT, CRE Shannon Walker MD,
Statins In COPD: A Systematic Review Surinder J, Kirly P et al. Chest 2009; 136: Divya Bappanad March 11, 2010 Journal Club.
© 2013 Global Initiative for Chronic Obstructive Lung Disease
Chronic Obstructive Pulmonary Disease. Why COPD is Important ? COPD is the only chronic disease that is showing progressive upward trend in both mortality.
Chronic Obstructive Pulmonary Disease
Habib GHEDIRA, MD, Prof. Medical Faculty of Tunis
The Detrimental Effects of Anxiety Secondary to COPD and its facilitation of Disease Progression and Decreased Quality of Life Ashley Anglin.
Lung Function Tests Normal and abnormal Prof. J. Hanacek, MD, PhD.
Normal and abnormal Prof. J. Hanacek, MD, PhD
GOLD Update 2011 Rabab A. El Wahsh, MD. Lecturer of Chest Diseases and Tuberculosis Minoufiya University REVISED 2011.
UNDERUSE OF SPIROMETRY BY FAMILY PHYSICIANS FOR THE DIAGNOSIS OF COPD IN ITALY G. Bettoncelli, G. Caramori, R. Tosatto, F. Arpinelli, G. Visonà, A. Gerace,
Advanced Asthma Training Course Mechanisms Of Asthma Part II Dr.Hadeel A.K AlOtair ABIM,MRCP(UK),FCCP Assisstant professor of Medicine consultant pulmonologist.
New Strategies of the EPR-3. – Asthma is a chronic inflammatory disorder of the airways – The immunohistopathologic features of asthma include inflammatory.
COPD Diagnosis & Management Anil Ramineni Specialist Respiratory Physiotherapist Community Respiratory Team.
Chronic Obstructive Pulmonary Disease Austin Paul K.
COPD AND LUNG CANCER Prof. Leonardo M. Fabbri Clinica di Malattie dell’Apparato Respiratorio Università di Modena e Reggio Emilia Modena, 12 Dicembre 2003.
COPD ) ) Chronic Obstructive Pulmonary Disease. Introduction n COPD is a preventable and treatable disease with some significant extrapulmonary effects.
Maggie Harris Independent Respiratory Nurse Specialist
CAPSTONE PROJECT. Setting the scene- why smoking cessation is important in the treatment of COPD.
Increased Risk of Exacerbation and Hospitalization in Subjects With an Overlap Phenotype (COPD-Asthma) Ana Maria B. Menezes, MD ; Maria Montes de Oca,
LSU Journal Club Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD WISDOM study H. Magnussen MD, et al. Nisha Loganantharaj, PGY1 April 21,
Daniel B. Jamieson, Elizabeth C. Matsui, Andrew Belli1, Meredith C. McCormack, Eric Peng Simon Pierre-Louis, Jean Curtin-Brosnan, Patrick N. Breysse, Gregory.
Chronic Obstructive Pulmonary Disease. COPD is an umbrella term for two diseases which cause progressive airflow obstruction Chronic Bronchitis- Inflammation.
Definition Chronic obstructive pulmonary disease (COPD) is characterized by chronic airflow limitation and a range of pathological changes in the lung.
Management of stable chronic obstructive pulmonary disease (2) Seminar Training Primary Care Asthma + COPD D.Anan Esmail.
Original article Chronic Renal Failure A Neglected Comorbidity of COPD Raffaele Antonelli Incalzi, MD; Andrea Corsonello, MD; Claudio Pedone, MD; Salvatore.
The ‘‘single airway’’ concept  The upper respiratory tract -nose and paranasal sinuses- has the same mucosal lining as the lower airways  Both compartments.
INCREASED RISK OF MYOCARDIAL INFARCTION AND STROKE FOLLOWING EXACERBATION OF COPD Gavin C. Donaldson, PhD ; John R. Hurst, PhD ; Christopher J. Smith,
The Use of Fraction of Exhaled Nitric Oxide in Pulmonary Practice Kaiser G. Lim, MD, FCCP; and Carl Mottram, RRT, RPFT CHEST 2008; 133:1232–124 Jeung Eun.
Chronic Obstructive Pulmonary Disease Clinacal Pharmacy.
GOLD 2017 major revision: Summary of key changes
External multicentric validation of a COPD detection questionnaire.
An effective COPD case finding strategy in Primary Care
A New Anti-inflammatory Therapy For COPD
COPD Report 5 Coles Lane, Oakington, Cambridge, CB24 3BA.
Classification of chronic obstructive pulmonary disease (COPD) severity according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD):
Greater Glasgow Outreach Spirometry Service: A model for closer collaboration between primary and secondary care and its impact on chronic lung disease.
Assessing COPD in Primary Care
Chronic Obstructive Pulmonary Disease (COPD) is a common, preventable and treatable disease that is characterized by persistent respiratory symptoms and.
Prof Dr Guy JOOS Dept Respiratory Medicine Ghent University Hospital
Relationship between the change in a) ventilatory and b) cerebrovascular responses in older healthy subjects (Older) and chronic obstructive pulmonary.
Rhinitis and asthma: Evidence for respiratory system integration
Occurrence of morning symptoms
Diagnosi della BPCO 1.
Gestione clinica della BPCO
3-year survival of lung cancer patients in the general population and in those with a prior diagnosis of chronic obstructive pulmonary disease (COPD).
Schematic overview of the suggested pharmacological management of chronic obstructive pulmonary disease (COPD). Schematic overview of the suggested pharmacological.
Correlation between inspiratory capacity (IC)/total lung capacity (TLC) ratio and oxygen pulse at peak exercise in chronic obstructive pulmonary disease.
Khai Hoan Tram, Jane O’Halloran, Rachel Presti, Jeffrey Atkinson
Presentation transcript:

J R Hurst Thorax : Depart. Of Pulmonology R3 백승숙

 COPD is defined by the presence of inflammation and airflow limitation in the lung  It is not widely appreciated that COPD is associated with sinonasal (upper airway) involvement  The upper respiratory tract (nose and paranasal sinuses) has the same mucosal lining as the lower airways  Both compartments are involved together in health and disease The ‘‘Single airway’’ concept

 The evidence supporting sinonasal involvement in COPD, interactions between the upper and lower airway, and the mechanisms and implications that may result from such interaction

 Sidestream smoke  nasal airway  Mainstream smoke  lung  USNHANES II data ; 191men, current smoking was associated with a five-fold increased risk of chronic rhinitis in a dose-dependent manner  Active cigarette smoking ; associated with an increased prevalence of nasal disease  Appropriate correction for smoking status must be considered Prolonged nasal mucociliary clearance Prolonged nasal mucociliary clearance Increased nasal resistance Increased nasal resistance

 Montnemery et al ; first data to suggest a higher prevalence of nasal symptoms in COPD than in the general population  van Manen et al  Roberts et al ; first to assess the prevalence of chronic nasal symptoms in a population with COPD confirmed at spirometry  A study from Greece

61 pts 61 pts Moderate to severe disease Moderate to severe disease (FEV1; 0.98 L, 37% predicted) (FEV1; 0.98 L, 37% predicted)

 COPD is associated with a higher prevalence of chronic nasal symptoms than found in control subjects, not solely attributable to active cigarette smoking and which persist after smoking cessation  The presence of chronic nasal symptoms suggests that COPD may be associated with chronic rhinosinusitis

Smoking-matched control group

 Ragab et al ; 60% of patients with chronic rhinosinusitis were found to have lower airway symptoms or spirometric abnormalities ◦ Patients who had asymptomatic airflow obstruction had a higher proportion of neutrophils in sinus washings ◦ The number of these neutrophils correlated with the degree of airflow obstruction  Rhinovirus-induced exacerbations ; increase in nasal IL8 concentration coinciding with the peak in nasal viral load ◦ Virus  Nasal inflammation : ICAM-1

 Pts with COPD have upregulated nasal inflammation compared with controls, additive to that associated with current cigarette smoking  This inflammation persists after smoking cessation, and the magnitude correlates with that present in the lower airway  There are also relationships between upper and lower airway bacterial carriage  Nasal inflammation is further upregulated at exacerbation, and the magnitude of the nasal inflammatory response at exacerbation relates to the severity of nasal symptoms

 Assessed using acoustic rhinometry  Patients with COPD experiencing chronic nasal symptoms  Narrower nasal airway  Significant correlation between the severity of nasal airway and pulmonary airflow obstruction

 Patients with COPD have more nasal symptoms than controls, which persist after smoking cessation  There is also a nasal inflammatory response in COPD, the severity of which relates to the severity of lower airway inflammation  A relationship between the severity of pulmonary airflow obstruction and obstruction to the nasal airway  COPD is associated with the coexistence of nasal symptoms, airway obstruction and inflammation symptoms, airway obstruction and inflammation

How might nasal involvement in COPD affect the lower airway?

 Hens et al ; SNOT (Sino-Nasal Outcome Test) questionnaire -- a validated disease-specific health status tool -- were significantly worse in the subjects with COPD  Dewan NA ; History of sinusitis was significantly more likely to be present in the patients who experienced one or more treatment failures than in those whose exacerbations always recovered (29% vs 9%, p=0.009)  Therapeutic nasal intervention might be a novel approach to therapy in COPD

 Definitive, larger investigation of sinonasal involvement in COPD - Be performed across the spectrum of COPD disease severity - Comprehensively assess nasal symptoms, examination findings, inflammation, bacterial carriage, sinonasal imaging and function  Sinonasal involvement in COPD with nasal treatment - Aiming to reduce nasal symptoms, improve quality of life, affect important lower airway outcomes such as exacerbations

 Practioners in otolaryngology might consider the diagnosis of COPD in patients with chronic rhinosinusitits, and practioners in respiratory medicine should consider identifying those COPD patients with chronic nasal symptoms COPD can be associated with upper airway (sinonasal) symptoms COPD can be associated with upper airway (sinonasal) symptoms that affect quality of life, and a nasal inflammatory process that affect quality of life, and a nasal inflammatory process